A small clinical trial shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors.

LOUISVILLE, Ky. -- More than half of patients with newly diagnosed metastatic kidney cancer responded to a novel drug ...

but had a change of heart following a review of its pipeline priorities in 2019 and decided to license the therapy out to Pharming for $20 million upfront plus milestones and royalties.

Subscription required for NFL+. Terms and conditions apply.